Please login to order a test.
Diabetes Comorbidity Assessment
This test is intended to help inform the clinician about the presence of hyperlipidemia as an index to cardiovascular disease and to identify patients with chronic kidney disease.
LDL cholesterol cannot be calculated if triglyceride is >400 mg/dL.
Lipid Profile With Non‐HDL Cholesterol: See individual tests.
Kidney Profile ‐ creatinine: kinetic jaffe. Albumin: immunoturbidimetric
The relationship between diabetes, cardiovascular disease, and chronic kidney disease is widely recognized. Among individuals with type 2 diabetes, cardiovascular disease is the leading cause of morbidity and mortality. Chronic kidney disease occurs in 20% to 40% of patients with diabetes and may be present at the time of diagnosis.
While not considered to be a clinical entity itself, individuals with prediabetes are at increased risk for diabetes and cardiovascular disease. Additionally, observational evidence has linked prediabetes with early nephropathy, chronic kidney disease, small fiber neuropathy, diabetic retinopathy, and increased risk of macrovascular disease.
Serum (preferred) or plasma and random urine
3 mL serum or plasma and 10 mL urine
1 mL serum or plasma and 2 mL urine
Red-top tube, gel-barrier tube, green-top (heparin) tube, or lavender-top (EDTA) tube and plastic urine container
Patient should be on a stable diet, ideally for two to three weeks prior to collection of blood, and should fast for 12 to 14 hours before collection of the specimen.
Separate serum or plasma from cells within 45 minutes of collection. Lipid panels are best avoided for up to three months following acute myocardial infarction, although cholesterol can be measured in the first 24 hours.
Collect random urine without preservatives. pH must be 4 to 8.
Maintain specimens at room temperature.
Causes for Rejection
Specimen with greatly elevated triglycerides (>400 mg/dL); improper labeling; hemolysis
State patient's age and sex on the request form.
|Order Code||Order Code Name||Order Loinc||Result Code||Result Code Name||UofM||Result LOINC|
|023400||Diabetes Comorbidity Risk||001370||Creatinine||mg/dL||2160-0|
|023400||Diabetes Comorbidity Risk||013672||Creatinine, Urine||mg/dL||2161-8|
|023400||Diabetes Comorbidity Risk||140097||Albumin, Urine||ug/mL||14957-5|
|023400||Diabetes Comorbidity Risk||140291||Alb/Creat Ratio||mg/g creat||9318-7|
|023400||Diabetes Comorbidity Risk||001065||Cholesterol, Total||mg/dL||2093-3|
|023400||Diabetes Comorbidity Risk||001172||Triglycerides||mg/dL||2571-8|
|023400||Diabetes Comorbidity Risk||011817||HDL Cholesterol||mg/dL||2085-9|
|023400||Diabetes Comorbidity Risk||011916||VLDL Cholesterol Cal||mg/dL||13458-5|
|023400||Diabetes Comorbidity Risk||012054||LDL Cholesterol Calc||mg/dL||13457-7|
|023400||Diabetes Comorbidity Risk||011976||Non-HDL Cholesterol||mg/dL||43396-1|
|023400||Diabetes Comorbidity Risk||011824||Comment:||77202-0|
|023400||Diabetes Comorbidity Risk||100791||eGFR If NonAfricn Am||mL/min/1.73||88284-4|
|023400||Diabetes Comorbidity Risk||100797||eGFR If Africn Am||mL/min/1.73||88294-4|